Aaron Pearce
Analyst · Wells Fargo
Thank you, Michael. Good morning, everyone. I'll start the financial review on Slide number 4. Sales in the third quarter were $295.5 million, which was an increase of 11.1% compared to the same quarter last year. And pretax income was $47.8 million, which was an increase of 116% compared to Q3 of last year. Diluted EPS finished at $0.71 this quarter compared to last year's third quarter EPS of $0.26. We also had another very strong quarter of cash generation. Cash provided by operating activities was $56 million, which is more than 30% higher than the $42.8 million of operating cash flow generated in the third quarter of last year. So financially, Q3 was a very strong quarter. Moving to Slide number 5, you'll find our quarterly sales trends. Our double digit sales growth consisted of organic growth of 6.5% and an increase from foreign currency translation of 4.6%. Organic sales continued to improve sequentially in our ID Solutions business and finished Q3 up a robust 9.8%. Our Workplace Safety business benefited from strong COVID related product sales in last year's third quarter. As a result of these tough comparables, we saw a decline in WPS organic sales of 2.2% this quarter. However, we remain optimistic about the future of our WPS business and we've increased our customer base, improved our digital presence and we have many new proprietary products, all of which bode well for the future. Turning to Slide number 6, you'll see our gross profit margin trending. Our gross profit margin increased by 170 basis points this quarter, finishing at a healthy 50.4% compared to 48.7% in the third quarter of last year. This improvement was a direct result of the increased sales volumes and the many efficiency activities that we've been driving throughout our manufacturing facilities. We're seeing inflationary pressures in raw materials, freight and certain services. We're also seeing wage inflation and we're finding it difficult to fill open manufacturing roles. However, even with these upward cost pressures, we were still able to improve our gross profit margins due to some targeted price increases combined with our never ending efficiency and automation focus. On Slide number 7, you'll find our SG&A expense trending. SG&A was $90.8 million this quarter compared to $83.2 million in the third quarter of last year. And as a percent of sales, SG&A ticked down to 30.7% from 31.3% in the same period of last year. The absolute dollar value of SG&A was negatively impacted by foreign currency due to the depreciation of the US dollar, additional personnel costs and increased incentive based compensation. In Q3 of this year, we had a higher than normal level of incentive based compensation, whereas in the third quarter of last year, incentive based comp was effectively nonexistent as commissions and bonuses were significantly reduced due to the pandemic. And as Michael mentioned, we are absolutely investing in sales and marketing to drive sales and take share as the world opens back up. Moving to Slide number 8. You'll find the trending of our investments in research and development. This quarter, we invested $11.3 million in R&D. We continue to have opportunities to invest in new product development, and we're committed to increasing these investments while, at the same time, ensuring that we get the most out of every dollar spent. These investments in R&D are critical to help propel Brady's long term sales growth and protect our gross profit margins. Slide number 9 illustrates our pretax income trends. Pretax income more than doubled from $22.2 million last year to $47.8 million this quarter. In Q3 of last year, pretax income was negatively impacted by $13.8 million of noncash impairment charges. Even after excluding these nonrecurring items from the prior year, this quarter's pretax income increased by 32.8% over the same period last year. The significant increase in earnings was due to our strong sales growth combined with our ongoing focus on expense management, thus dropping more of every dollar of sales to pretax income. Slide number 10 illustrates our after-tax income and EPS trends. As I mentioned, diluted EPS was $0.71 this quarter compared to $0.26 in last year's third quarter, an increase of 173%. If you adjust our prior year EPS for the impairment that I just mentioned, our EPS growth would have been a very strong 51% this quarter. On Slide number 11, you'll find a summary of our cash generation, which continues to be quite strong. We generated $56 million of cash flow from operating activities and free cash flow was $49.1 million this quarter. When compared to last year's third quarter, this represents a 31% increase in cash flow from operating activities and a 43% increase in free cash flow. Looking at cash flow from operating activities as a percent of earnings, operating cash flow was equal to 150% of net income this quarter, continuing to illustrate the strong quality of our earnings. Now if you'll turn to Slide number 12, you can see the impact that the strong cash generation is having on our balance sheet. On April 30th, we had $321.8 million of cash and no outstanding debt. This quarter our cash balance increased by approximately $44 million even after returning $11.5 million to our shareholders in the form of dividends and investing $6.9 million in capital expenditures. As of today, we have not yet closed the acquisition of Nordic ID. However, this acquisition, when closed, will barely put a dent in our cash balance and we will still be in a net cash position of over $300 million. Our strong balance sheet puts us in a fantastic position to execute additional shareholder value enhancing activities, including investing in R&D and completing additional acquisitions. Our approach to capital allocation is consistent. First, we use our cash to fully fund organic sales and efficiency opportunities throughout the economic cycle. We're funding investments in new product development, sales generating resources, IT improvements, capability enhancing capital expenditures and CapEx to further automate our facilities. We will absolutely keep funding these investments where it makes sense and where the investments are long term ROI positive. And second, we focus on returning cash to our shareholders in the form of dividends. Fiscal '21 marks our 35th consecutive year of annual dividend increases. After funding organic investments and dividends, we then deploy our cash in a disciplined manner for either buybacks or acquisitions where we believe that we have strong synergistic opportunities. Let's move along to our outlook for the rest of fiscal 2021, which is articulated on Slide number 13. Our Q3 results were a bit stronger than we had anticipated and these stronger results are factoring into our incrementally more positive view on the remainder of this fiscal year. In addition, we're also seeing improving economic conditions in most of our end markets, but the improvements have not been steady and they haven't impacted all of our end markets evenly. We're increasing our guidance range for the fiscal year ending July 31, 2021, from the previously announced range of $2.48 to $2.58 per share to our new guidance range of $2.58 to $2.68 per share, which equates to a range of $0.64 to $0.74 in the fourth quarter. This implies that we expect the EPS to improve somewhere in the range of 20% to 40% in the fourth quarter of this year when compared to the fourth quarter of last year. We also anticipate that organic revenues will increase somewhere in the low teen percentages in Q4. This guidance is, of course, contingent upon continued macroeconomic improvements. We'll continue to make the investments necessary to drive organic sales growth. We'll continue to search for acquisitions that advance our strategies, and we'll continue to drive sustainable efficiency gains while being tight on non revenue generating expenses. We're confident that we've taken, and will continue to take right actions today to deliver strong revenue and earnings growth as we exit fiscal 2021 and enter our fiscal year 2022. I'll now turn the call back over to Michael to cover our divisional results and to provide some closing comments before the Q&A session. Michael?